Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling.
about
Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprosthesesTargeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging GliomasAngiogenesis and liver fibrosisA heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesisMatrix metalloproteinases: regulators of the tumor microenvironmentMultiscale models of angiogenesisFunctional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells.Visualization of polarized membrane type 1 matrix metalloproteinase activity in live cells by fluorescence resonance energy transfer imagingEndothelial podosome rosettes regulate vascular branching in tumour angiogenesis.Angiopoietin-like protein 2 regulates endothelial colony forming cell vasculogenesisExtracellular matrix, inflammation, and the angiogenic response.Concentration independent modulation of local micromechanics in a fibrin gel.Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration.Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cellsLocalizing matrix metalloproteinase activities in the pericellular environment.Physiology and pathophysiology of matrix metalloproteases.Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit.Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinaseMT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectinProteolytic Enzymes Clustered in Specialized Plasma-Membrane Domains Drive Endothelial Cells' Migration.Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms.Endothelial cell regulation of matrix metalloproteinases.The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.Matrix metalloproteases: underutilized targets for drug deliveryIn vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents.Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodelingMembrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization.Vascular endothelial growth factor and substrate mechanics regulate in vitro tubulogenesis of endothelial progenitor cells.Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis.Podosome-like structures of non-invasive carcinoma cells are replaced in epithelial-mesenchymal transition by actin comet-embedded invadopodia.Obese-derived ASCs show impaired migration and angiogenesis properties.Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.In vitro evaluation of functional interaction of integrin alphavbeta3 and matrix metalloprotease-2.A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1-MMP.Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.Targeting the tumor microenvironment by immunotherapy: part 2.MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.In vivo modulation of the inflammatory response by nonsteroidal antiinflammatory drug-related compounds that trigger L-selectin shedding.CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain.
P2860
Q24338121-CC9790D8-518A-443D-8A3A-26F6B9B5A6B4Q27335251-BD71D7AA-5707-4B10-B158-69D2CAA06A7BQ28082569-3AD0C0AB-1BA5-400D-8558-7E1929625C99Q28731921-AE7CBCFD-F0DF-48A6-82B1-A8F609400622Q29619858-43F55AA1-351E-4CCE-A200-014EA64F8138Q30432668-F973D94C-A2CE-41ED-A1CD-F8EC5CC0E583Q30480215-EB4CCE4E-6A13-4DE3-8120-33C50330F7BDQ30482313-D6EA3FD1-A202-4210-8FA6-8FF4D94D245FQ30664059-F680B886-4110-4E0E-8D3E-F68A6F60C1C5Q33779371-2B3AD908-88FD-48A9-A211-B245515402F2Q33795730-2CD5928E-7E05-4AB6-8AAE-8810CD409A2BQ33918441-BB0DA358-C769-449C-8391-CF477372C887Q33928475-5755E22B-52D1-4E43-9C8A-84235D64B60AQ34269018-A5D72AE2-72F9-4835-8854-6F7EC505B618Q34418625-58C0DA39-11A9-4190-81C1-C11F3554EC31Q35007715-95E9698C-BFDE-4535-B8FA-7362B533D440Q35221935-99F9D088-BD5A-4968-BC03-3318EBC5B47EQ35313033-BB39797F-6B58-40DA-A5AE-180DB201C6C4Q35588436-12CA22DB-0B89-4F2A-91A7-534D20F6F99FQ35630660-0C5F5D87-0E66-4157-963C-F6347C7F98CBQ36010461-7AA9D809-BF94-4F1C-833E-86F681B01F61Q36015755-99D3C600-FE49-4301-AA64-C50DB46FB083Q36066998-5839EA56-0D4E-4B7D-A659-1F244C044D62Q36719208-C8D1A7D4-79AF-4641-9F37-194F59611190Q36761849-FABD5237-8835-4D83-BE03-F3C1637325EAQ36882183-435FCEFE-AF01-459D-8D58-6C452F3EF46EQ36960275-108D5EB2-ACB5-4116-AF8E-5500DDFDA99DQ37164593-1695BE54-489E-4A5B-BF5B-CE67DEC4B6D5Q37295378-7A0026F3-4B58-4006-AB98-080A6D4007B5Q37297991-928CEF27-3371-42A0-A934-8AC02A0A431BQ37310999-3B4C5FA3-BC02-484C-BC1B-63CC001F9089Q37332094-1ED2CBA9-E554-4B63-8FD7-C78C4B22AEEDQ37401556-5A793E3E-43A4-4009-9518-1B2985673F08Q37467465-A1F68B51-CC24-4865-BEF4-05CDE85DA44FQ37614524-7FCA9D43-6A71-4329-865D-E90DD19FBBEDQ37628695-496C4B7C-4C1D-4742-B745-F540328F2BBCQ37952796-375D76E8-89F5-4C3D-8E9E-AAF346F19073Q39037632-92D56E54-B6CA-4F66-8533-E02C2D18B12FQ39279178-9C645A6A-018B-469F-9250-EE57DF57E330Q39647831-10DCF209-951D-4AE1-9E7B-7A6EC7971C41
P2860
Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@en
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@nl
type
label
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@en
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@nl
prefLabel
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@en
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@nl
P2093
P2860
P356
P1476
Membrane type 1-matrix metallo ...... otility and matrix remodeling.
@en
P2093
Matías-Román S
P2860
P304
37491-37500
P356
10.1074/JBC.M104094200
P407
P577
2001-07-11T00:00:00Z